Figure 1From: Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patientsTracking circulating tumor cell (CTC) counts from a metastatic breast cancer patient (ID# 18) in response to different therapies (Ariol® vs. CellSearch™).Back to article page